türk toraks derneği kronik obstrüktif akciğer hastalığı tanı ve tedavi

TÜRK TORAKS DERNEĞİ KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞI TANI VE TEDAVİ UZLAŞI RAPORU
75. ATS/ERS Statement on Pulmonary Rehabilitation. Am J
Respir Crit Care Med 2006; 173: 1390-413.
76. Clark CJ, Decramer M. The definition and rational for pulmonary
rehabilitation. In: Donner CF, Decramer M; eds.
ERS Pulmonary Rehabilitation Monograph 2000; 13: 1-6.
77. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary
Rehabilitation: Joint ACCP/AACVPR Evidence-based Clinical
Practice Guidelines. Chest 2007; 131: 4-42.
78. Takigava N, Tada A, Soda R, et al. Comprehensive pulmonary
rehabilitation according to severity of COPD.
Respiratory Medicine 2007; 101: 326-32.
79. ATS/ERS Task Force. Standards for the diagnosis and the
treatment of patients with COPD: a summary of the ATS/
ERS position paper. Eur Respir J 2004; 23: 932-46.
80. Donner CF, Lusuardi M. Selection of candidates and programmes.
In: Donner CF, Decramer M; eds. ERS Pulmonary
Rehabilitation Monograph. 2000; 13: 132-43.
81. AACVPR Guidelines for pulmonary rehabilitationprograms.
3 rd ed. Human Kinetics. 2005.
82. ZuWallak R. High versus low intensity exercise training in
pulmonary rehabilitation: is more better Chronic
Respiratory Disease 2004; 1: 143-9.
83. Vogiatsiz I, Nanas S, Roussos C. Interval training as an
alternative modality to continuous exercise in patients with
COPD. Eur Respir J 2002; 20: 12-9.
84. Trooster T, Cassaburi R, Gosselink R, Decramer M.
Pulmonary rehabilitation in patients with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 1999;
160: 1248-53.
85. Laccase Y, Wong E, Guyatt GH, et al. Metaanalysis of respiratory
rehabilitation in patients with chronic obstructive
pulmonary disease. Lancet 1996; 348: 1115-9.
86. Costi S, Crisafulli E, Antoni FD, et al. Effects of unsupported
upper extremity exercise training in patients with COPD: A
randomized clinical trial. Chest 2009; 136: 387-95.
87. Neish CM, Hopp JW. The role of education in pulmonary
rehabilitation. J Cardiopulm Rehabil 1988; 11: 439-41.
88. Wouters EFM, Schols A. Nutritional support in chronic
respiratory disease. In: Donner CF, Decramer M; eds.
ERS Pulmonary Rehabilitation Monograph 2000; 13:
111-31.
89. Emery CF, Green MR, Suh S. Neuropsychiatric Function in
Chronic Lung Disease: the Role of Pulmonary Rehabilitation.
Respir Care 2008; 53: 1208-16.
90. Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR.
Pulmonary rehabilitation improves depression, anxiety,
dyspnea and health status in patients with COPD. Am J
Phys Med Rehabil 2007; 86: 30-6.
91. Umut S. Kronik Obstrüktif Akciğer Hastalığında Oksijen
Tedavisi. Tanımdan Tedaviye Kronik Obstrüktif Akciğer
Hastalığı. Toraks Kitapları 6. (Ed: S. Umut, E. Erdinç)
İstanbul, 2008; 177-84.
92. Turhan K, Çağırıcı. Kronik Obstrüktif Akciğer Hastalığında
Cerrahi Tedavi. Tanımdan Tedaviye Kronik Obstrüktif
Akciğer Hastalığı. Toraks Kitapları 6 (Ed: S. Umut, E. Erdinç)
İstanbul, 2008; 308-18.
93. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic
lung volume reduction on dynamic hyperinflation
and exercise in emphysema. Am J Respir Crit Care Med
2005; 171: 453-60.
94. Ambrosino N, Gherardi M, Carpenè N. End stage chronic
obstructive pulmonary disease. Pneumonol Alergol Pol
2009; 77: 173-9.
95. Smetana GW. Preoperative pulmonary evaluation. N Engl J
Med 1999; 340: 937-44.
96. Demir T. KOAH’da preoperatif değerlendirme. In: Saryal
SB, Acıcan T, ed. Güncel bilgiler ışığında kronik obstrüktif
akciğer hastalığı. İstanbul: Bilimsel; 2003: 321-31.
97. Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary
risk stratification for noncardiothoracic surgery: a
systematic review for the American College of Physicians.
Ann Intern Med 2006; 144: 581-95.
98. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the
diagnosis and care of patients with COPD: a summary of the
ATS/ERS position paper. Eur Respir J 2004; 23: 932-46.
99. GOLD. NHLBI/WHO Global Intitative for Chronic
Obstructive Lung Disease (GOLD) Workshop report. Global
strategy for the diagnosis, management and prevention of
chronic obstructive pulmonary disease 2009. www.goldcopd.com.
100. Afessa B, Morales IJ, Scanlon PD, Peters SG. Prognostic
factors, clinical course, and hospital outcome of patients
with chronic obstructive pulmonary disease admitted to an
intensive care unit for acute respiratory failure. Crit Care
Med 2002; 30: 1610-5.
101. Groenewegen KH, Schols AM, Wouters EF. Mortality and
mortality related factors after hospitalization for acute
exacerbation of COPD. Chest 2003; 124: 459-67.
102. Sapey E, Stockley RA. COPD exacerbations 2: Aetiology.
Thorax 2006; 61: 250-8.
103. Vestbo J. Clinical assessment, staging, and epidemiology
of chronic obstructive pulmonary disease exacerbations.
Proc Am Thorac Soc 2006; 3: 252-6.
104. Siddiqi A, Sethi S. Optimizing antibiotic selection in treating
COPD exacerbations. International J COPD 2008; 3: 31-44.
105. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic
therapy in exacerbations of chronic obstructive pulmonary
disease. Ann Intern Med 1987; 106: 196-204.
106. Soto FJ, Varkey B. Evidence-based approach to acute exacerbations
of COPD. Curr Op Pulm Med 2003; 9: 117-24.
107. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary
embolism in acute exacerbations of COPD: a systematic
review and metaanalysis. Chest 2009; 135: 786-93.
108. NICE. Chronic obstructive pulmonary disease Management
of chronic obstructive pulmonary disease in adults in primary
and secondary care. NICE website 2004. www.nice.
org.uk/CG012NICEguideline.
109. Calverley PMA. Respiratory failure in chronic obstructive
pulmonary disease. Eur Respir J 2003; 22: 26-30.
110. Roisin RR. COPD exacerbations 5: Management. Thorax
2006; 61: 535-44.
111. Polatli M, Dayanir V, Polatli Ö et al. The effect of ipratropium
bromide on intraocular pressure in patients with chronic
obstructive pulmonary disease: An open label study.
Curr Ther Res Clin Exp 2002; 63: 380-7.
57